Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP892429.RA3wOARPV_SSMqQMRNb7Vs28ofGKqPdBSnQ53l-ft4K4E130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP892429.RA3wOARPV_SSMqQMRNb7Vs28ofGKqPdBSnQ53l-ft4K4E130_assertion type Assertion NP892429.RA3wOARPV_SSMqQMRNb7Vs28ofGKqPdBSnQ53l-ft4K4E130_head.
- NP892429.RA3wOARPV_SSMqQMRNb7Vs28ofGKqPdBSnQ53l-ft4K4E130_assertion wasGeneratedBy ECO_0000203 NP892429.RA3wOARPV_SSMqQMRNb7Vs28ofGKqPdBSnQ53l-ft4K4E130_provenance.
- NP892429.RA3wOARPV_SSMqQMRNb7Vs28ofGKqPdBSnQ53l-ft4K4E130_assertion wasDerivedFrom befree-2016 NP892429.RA3wOARPV_SSMqQMRNb7Vs28ofGKqPdBSnQ53l-ft4K4E130_provenance.
- NP892429.RA3wOARPV_SSMqQMRNb7Vs28ofGKqPdBSnQ53l-ft4K4E130_assertion SIO_000772 21551260 NP892429.RA3wOARPV_SSMqQMRNb7Vs28ofGKqPdBSnQ53l-ft4K4E130_provenance.
- NP892429.RA3wOARPV_SSMqQMRNb7Vs28ofGKqPdBSnQ53l-ft4K4E130_assertion evidence source_evidence_literature NP892429.RA3wOARPV_SSMqQMRNb7Vs28ofGKqPdBSnQ53l-ft4K4E130_provenance.
- NP892429.RA3wOARPV_SSMqQMRNb7Vs28ofGKqPdBSnQ53l-ft4K4E130_assertion description "[We have assessed the therapeutic efficacy of E7080, an orally available inhibitor of multiple tyrosine kinases including VEGF receptor 2 (VEGFR-2) and VEGFR-3, in experimental multiple organ metastasis of lung cancer cell lines without EGFR mutations.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP892429.RA3wOARPV_SSMqQMRNb7Vs28ofGKqPdBSnQ53l-ft4K4E130_provenance.